Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lisinopril manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

2 products found

lisinopril

Tablets 10mg, 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Lisinopril manufacturers

What is Lisinopril?

Lisinopril is a medication that belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is commonly used to treat high blood pressure, heart failure and to improve survival after a heart attack.

Lisinopril works by blocking the activity of ACE, which converts angiotensin I to angiotensin II. By blocking the activity of ACE, Lisinopril helps to relax blood vessels, lower blood pressure, and reduce the workload on the heart.

Lisinopril is taken orally, usually once daily, with or without food. 

As with all medications, Lisinopril may cause side effects, including dizziness, headache, cough, fatigue, and gastrointestinal upset. In rare cases, it may also cause more serious side effects such as kidney problems, allergic reactions, or low blood pressure.

Lisinopril forms and dosage

Lisinopril is available in different forms and dosages. The most common form is an oral tablet, but it can also be found in other formulations, such as oral solution.

Lisinopril tablets come in various strengths, including 2.5mg, 5mg, 10mg, 20mg, 30mg, and 40mg. The recommended dosage of Lisinopril depends on the condition being treated and other factors such as age, weight, and overall health. The usual starting dose for high blood pressure is 10mg once daily, and the maximum dose is typically 40mg per day.

The starting dose for heart failure is usually 2.5-5 mg once daily, which may be increased gradually over time to a maximum dose of 40mg daily. For patients with a recent heart attack, the starting dose is usually 5mg once daily, which may be increased to 10mg after several days.

Lisinopril oral solution is available in a concentration of 1mg/mL. The recommended dosage of the oral solution is usually the same as for the tablet form, but it may be adjusted based on individual needs and the instructions of the prescribing healthcare provider.

Lisinopril patent information

The patent for Lisinopril has expired, and the drug is now widely available as a generic medication. The original patent for Lisinopril was held by Merck & Co., Inc., and it was first filed in 1980. The patent was granted in 1984 and expired in 2001.

Generic Lisinopril is sold under a variety of brand names and is available in various strengths and formulations.

Lisinopril wholesale price

In the United States, Lisinopril tablet costs vary on the final dosage form:

  • 2.5 mg tablet costs from $0.11 to $0.41
  • 5 mg tablet costs from $0.07 to $0.51
  • 10 mg tablet costs from 0.10 to 0.89
  • 20 mg tablet costs from $0.07 to 0.80
  • 30 mg tablet costs from $0.24 to $1.53
  • 40 mg a tablet costs from $0.12 to $1.44.

In the United Kingdom, Lisinopril NHS cost was about ₤10 per month in 2018. 

In France, Lisinopril 20 mg price is around 4.5 EUR per 28-tablet pack.

Lisinopril manufacturers and brands

Lisinopril is a globally found drug under generic and trade names. The most known brand name for Lisinopril is Zestril by Merck, but as the patent expired in 2002, many manufacturers have started producing their products. 

Among these Lisinopril brand names, we can list Acebitor by GlaxoSmithKline, Acerbon by AstraZeneca, Acinopril and Fosinopril by Sanofi-Aventis, Bellisin by Ranbaxy, Biopril by Biochem, Dapril by Medochemie, Fibsol by Sigma, Hipril by Micro Labs, Presiten by Magnachem, Ranolip and Sinopren by Ranbaxy, Rantex by Biotech, Tensopril by Merck.

Lisinopril is produced by different manufacturers, such as Actavis Elizabeth Llc, Apotex Inc Etobicoke Site, Aurobindo Pharma Ltd, Lupin Ltd, Mylan Pharmaceuticals Inc, Ranbaxy Pharmaceuticals Inc, Sandoz Inc, Teva Pharmaceuticals USA Inc, Vintage Pharmaceuticals Llc, Watson Laboratories Inc.

Connecting to Lisinopril manufacturers and suppliers

Pipelinepharma is a B2B online marketplace that can help pharma buyers source Lisinopril thanks to:

  1. Extensive supplier network of verified manufacturers, which can help find reliable suppliers of Lisinopril.
  2. Competitive pricing: The platform allows buyers to compare prices and negotiate deals directly with suppliers, which can help find the most competitive pricing for Lisinopril.
  3. Quality assurance: Pipelinepharma verifies the quality and authenticity of the products and suppliers before they are listed on the platform, providing an added layer of assurance to buyers.
  4. Efficient sourcing: Pipelinepharma's search and filter options can help buyers quickly find the specific product and supplier they need, saving time and effort in the sourcing process.

More than 100 Lisinopril products are in the Pipelinepharma marketplace, listed in the Generics category. There are products with EU GMP approvals and several ready-to-file EU CTD dossiers.

In addition to tablets, buyers can submit business inquiries for the oral solution of Lisinopril.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation